|
KMID : 1148920220560050259
|
|
Nuclear Medicine and Molecular Imaging
2022 Volume.56 No. 5 p.259 ~ p.262
|
|
|
68Ga-DOTATATE Avid Metastatic Vertebral Renal Cell Carcinoma in the Setting of von Hippel-Lindau Syndrome
|
|
Patel Mayank
Jha Abhishek
Antic Tatjana
Nielsen Sarah M.
Churpek Jane E.
Ling Alexander
Pacak Karel
|
|
|
Abstract
|
|
|
|
Although rare, a metastatic renal cell carcinoma could present with 68Ga-DOTATATE avidity. A 66-year-old man with von Hippel-Lindau syndrome (VHL) presented with 68Ga-DOTATATE uptake in the pancreatic head, splenic hilar region, and multiple osseous sites, including the right lateral portion of the T9 vertebrae. Biopsy of the T9 lesion confirmed metastatic renal cell carcinoma. Various VHL-associated cancers may display 68Ga-DOTATATE avidity, which can change and guide clinical decisions for the patient.
|
|
|
KEYWORD
|
|
|
von Hippel-Lindau, 68Ga-DOTATATE, Renal cell carcinoma, Pheochromocytoma, Paraganglioma, Somatostatin receptors
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|